Cognate provides full development and cGMP manufacturing services to companies engaged in the development of cell-based products. Founded in 2002, Cognate BioServices is backed by investors that include EW Healthcare Partners, Medivate Partners, and Tennenbaum Capital Partners and is headquartered in Hanover.